跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
antibiotic (Mycobacterium tuberculosis)
首页
药物
antibiotic (Mycobacterium tuberculosis)
antibiotic (Mycobacterium tuberculosis)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Oxazolidinone derivatives
US 7816379 B2
申请人: DONG A PHARM CO LTD
优先权: 2003
CN
US
8 件公开
Bacteriophages for treatment of tuberculosis
US 12016892 B2
申请人: UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
优先权: 2022
US
5 件公开
Covalent microparticle-drug conjugates for biological targeting
US 6455073 B1
申请人: ENZREL INC
优先权: 2000
US
3 件公开
Prokaryotic proteasomal proteases of Mycobacterium tuberculosis (MTB) as targets for antibiotic therapy
US 7282491 B2
申请人: CORNELL RES FOUNDATION INC
优先权: 2003
US
2 件公开
Antibiotic comprising an antibody mimetic, its preparation methods and uses thereof
US 9073989 B2
申请人: QIU XIAOQING
优先权: 2011
US
2 件公开
Use of kinase inhibitors to manage tuberculosis and other infectious diseases
US 10537574 B2
申请人: UNIV EMORY
优先权: 2016
US
2 件公开
Application of HCK agonist in resisting mycobacterium tuberculosis infection
CN 119454967 A
申请人: BEIJING CHEST HOSPITAL CAPITAL MEDICAL UNIV
优先权: 2024
CN
2 件公开
Application of sodium deoxy taurocholate as synergist for antituber culosis antibiotic
CN 1337232 A
申请人: HUANG LINJUN
优先权: 2001
CN
Application of sodium taurocholate as synergist for antituberculosis antibiotic
CN 1337231 A
申请人: HUANG LINJUN
优先权: 2001
CN
Unmarked deletion mutants of mycobacteria and methods of using same
US 2003059441 A1
申请人: PAVELKA MARTIN S
优先权: 2002
US
第 1 / 3 页
上一页
下一页
药物
反馈